Results 111 to 120 of about 40,678 (327)

Health‐Related Quality of Life in Relation to the 5‐2‐1 Criteria in Parkinson's Disease in Sweden

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Device‐aided therapies (DAT) offer alternatives to oral or transdermal dopaminergic treatments in advanced Parkinson's disease (PD), where they can reduce motor fluctuations and dyskinesia and improve health‐related quality of life (HRQoL).
Frida Hjalte, Anna Gustafsson, Jenny Samuelsson, Filip Bergquist, Anders Johansson, Per Odin   +5 more
wiley   +1 more source

Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease

Neurobiology of Disease
Neural oscillations are critical to understanding the synchronisation of neural activities and their relevance to neurological disorders. For instance, the amplitude of beta oscillations in the subthalamic nucleus has gained extensive attention, as it ...
Xuanjun Guo, Shenghong He, Xinyi Geng, Pan Yao, Christoph Wiest, Yingnan Nie, Huiling Tan, Shouyan Wang   +7 more
doaj   +1 more source

The Unseen Burden: Uncovering Shame and Its Determinants in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Shame is frequent in Parkinson's disease (PD) and often overlooked. Objective The aim was to assess factors associated with PD‐related shame. Methods PD‐related shame was measured using the Shame and Embarrassment in PD (SPARK) scale in patients without cognitive impairment.
Sabina Catalano Chiuvé, Damien Benis, Charline Rime, Maria João Forjaz, Paul Krack, Carmen Rodriguez‐Blazquez, Vanessa Fleury   +6 more
wiley   +1 more source

Management of Anxiety in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry, Harry Costello, Silvia Jesús, Gary Price, Ashwani Jha   +4 more
wiley   +1 more source

Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Iron deposition and atrophy of the subthalamic nucleus (STN) have been reported in progressive supranuclear palsy (PSP). Quantitative susceptibility mapping (QSM), an advanced MRI technique, enables noninvasive assessment of the magnetic susceptibility of biological tissue and has been reported to have good ability to delineate STN.
Shotaro Haji, Wataru Sako, Kenta Hanada, Tomoyasu Matsubara, Yusuke Osaki, Yuki Matsumoto, Masafumi Harada, Yuishin Izumi   +7 more
wiley   +1 more source

Modeling effect of GABAergic current in a basal ganglia computational model

, 2012
Electrical high frequency stimulation (HFS) of deep brain regions is a method shown to be clinically effective in different types of movement and neurological disorders.
Claussen, Jens Christian, Hofmann, Ulrich G., Moser, Andreas, Njap, Felix   +3 more
core   +1 more source

Sustained Therapeutic Benefits Using Image‐Guided Programming at Activation of Deep Brain Stimulation for Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The efficacy of deep brain stimulation (DBS) for Parkinson's disease (PD) depends on optimizing stimulation parameters for each patient, a time‐sensitive process. Image‐guided programming (IGP) offers a promising method to streamline this.
Jason L. Aldred, Theresa Zesiewicz, Michael S. Okun, Adolfo Ramirez‐Zamora, Okeanis E. Vaou, Leo Verhagen Metman, Corneliu C. Luca, Ritesh Ramdhani, Jennifer Durphy, Yarema B. Bezchlibnyk, Jonathan D. Carlson, Kelly D. Foote, Sepher B. Sani, Alexander M. Papanastassiou, Jonathan R. Jagid, David B. Weintraub, Julie Pilitsis, Andres Hurtado, Rajat S. Shivacharan, Benjamin Reese, Edward Goldberg   +20 more
wiley   +1 more source

A Closer Look at the Psychiatric Effects of Deep Brain Stimulation to Further Guide Treatment of Refractory Epilepsy: A Focused Review [PDF]

, 2020
Introduction: Effective treatment of medically-refractory epilepsy remains a formidable challenge in many patients. The SANTE trial (2010) led to the FDA approval of deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) for the ...
Smith, LaTangela
core   +1 more source

Compressive Cervical Myelopathy Causing Impaired Gait after Deep Brain Stimulation Is Not Rare

Movement Disorders Clinical Practice, EarlyView.
Caroline Weill, Sami Heymann, Roy Dayan, Eduard Linetsky, Hagai Bergman, Zvi Israel, David Arkadir   +6 more
wiley   +1 more source

The Impact of Deep Brain Stimulation of the Subthalamic Nucleus on Sleep–Wake Function and Circadian Rhythms in Patients with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well‐established therapy in advanced Parkinson's disease (PD) improving motor and non‐motor signs including sleep. The mechanisms of sleep improvement are insufficiently understood.
Julia Steinhardt, Laura Lokowandt, Cosima Xenia Schmidt, Dirk Rasche, Henrik Oster, Britta Wilms, Norbert Brüggemann   +6 more
wiley   +1 more source